MeSH D065768 - lennox gastaut syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D030342:Inborn genetic diseases
D000073376:Epileptic syndromes
D065768:Â
Lennox gastaut syndrome
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Clobazam | Clobazam |  | 2019-05-23 |  |  |
| Topiramate | Topiramate |  | 2009-03-27 |  |  | |
| Ajanta Pharma | Topiramate | Topiramate |  | 2023-08-15 |  |  |
| Alkem Laboratories | Clobazam | Clobazam |  | 2019-09-06 |  |  |
| Topiramate | Topiramate |  | 2023-06-20 |  |  | |
| Allergan | Topiramate | Topiramate |  | 2009-03-27 |  |  |
| Amneal Pharmaceuticals | Clobazam | Clobazam |  | 2018-10-22 |  |  |
| ANDA Repository | Clobazam | Clobazam |  | 2020-12-09 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
100%3/3
Phase 2
100%3/3
Phase 3
57%8/14
Approved: 6Overall Success rate: 57%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use